High Vista Strategies LLC I Teos Therapeutics, Inc. Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$16.57 - $35.1 $64,606 - $136,854	-3,899 Reduced 17.09%	18,913 $390,000
Q1 2022 May 16, 2022	SELL	$31.92 - $47.45 $372,666 - $553,978	-11,675 Reduced 33.85%	22,812 $734,000
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $904,594 - $1.65 Million	34,487 New	34,487 $1.61 Million
Q2 2021 Aug 16, 2021	SELL	$17.9 - $36.1 $354,491 - $714,924	-19,804 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.86 - $44.2 $59,374 - $85,040	1,924 Added 10.76%	19,804 $677,000
Q4 2020 Feb 16, 2021	BUY	$21.59 - $33.95 $386,029 - $607,026	17,880 New	17,880 $605,000

169

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $285M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.